<DOC>
	<DOC>NCT00394069</DOC>
	<brief_summary>The purpose of this study is to look at the preliminary safety profile of an investigational drug in children 3 to 6 months of age with bronchiolitis.</brief_summary>
	<brief_title>PK Study in 3- to 6- Month-Old Children (0476-268)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Inclusion Criteria : Active bronchiolitis or a history of bronchiolitis and asthmalike symptoms Exclusion Criteria : A history of any significant illness that will pose additional risk to the patient</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>